Akebia Therapeutics, Inc. AKBA
0.39 USD -0.04 (-8.71%)
Regular-session close
0.40 +0.01 +3.50%
After hours · Nov 20, 7:50 PM ET
0.3849 Day range 0.4331
0.361 52-week range 1.73
- YTD
- -76.06%
- 1 year
- -74.97%
AKBA revenue history
Revenue is income from the company’s ordinary business activities.
236,196,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 236,196,000 | 76,016,000 | 47.46% |
| FY 2024 | 2024-12-31 | 160,180,000 | -34,443,000 | -17.70% |
| FY 2023 | 2023-12-31 | 194,623,000 | -97,861,000 | -33.46% |
| FY 2022 | 2022-12-31 | 292,484,000 | 80,834,000 | 38.19% |
| FY 2021 | 2021-12-31 | 211,650,000 | -82,994,000 | -28.17% |
| FY 2020 | 2020-12-31 | 294,644,000 | -40,357,000 | -12.05% |
| FY 2019 | 2019-12-31 | 335,001,000 | 127,259,000 | 61.26% |
| FY 2018 | 2018-12-31 | 207,742,000 | 26,515,000 | 14.63% |
| FY 2017 | 2017-12-31 | 181,227,000 | 179,692,000 | 11706.32% |
| FY 2016 | 2016-12-31 | 1,535,000 | 1,535,000 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-28 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-08-07T06:01:41.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
